Identifying systemic mastocytosis early can significantly impact patient outcomes, as highlighted in a recent session at the 2025 Society of Dermatology Physician Associates (SDPA) Fall Conference....
Identifying systemic mastocytosis at an early stage can significantly improve patient outcomes. This rare disease often first presents as skin abnormalities, emphasizing the need for clinicians...
Scientists at The University of Texas MD Anderson Cancer Center have developed a novel genome-wide CRISPR screening tool that significantly improves the efficacy of natural killer...
